This inventor holds 1 USPTO granted patent. Top assignee: Boryung Pharmaceutical Co., Ltd.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Jae-seog Kang: Innovator in Pharmaceutical Compounds
Introduction
Jae-seog Kang is a notable inventor based in Kunpo, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that have therapeutic applications.
Latest Patents
One of his key patents is focused on pyrimidinone compounds, which are pharmaceutical compositions containing these compounds. The patent describes a process for preparing these compounds, which exhibit remarkable antagonistic action against the angiotensin II receptor. This innovation is particularly useful in treating cardiovascular diseases caused by the binding of angiotensin II to its receptor. Jae-seog Kang holds 1 patent in this area.
Career Highlights
Jae-seog Kang is associated with Boryung Pharmaceutical Co., Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His research and development efforts have contributed to advancements in drug formulations and therapeutic strategies.
Collaborations
He has collaborated with notable colleagues, including Jae-hyoung Lee and Kyung-jin Jang, to further enhance the impact of his research and innovations.
Conclusion
Jae-seog Kang's work in developing pyrimidinone compounds showcases his commitment to advancing medical science and improving treatment options for cardiovascular diseases. His contributions are a testament to the importance of innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile